
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CAR Treg: A new approach in the treatment of autoimmune diseases
Seyedeh Ameneh Beheshti, Karim Shamsasenjan, Majid Ahmadi, et al.
International Immunopharmacology (2021) Vol. 102, pp. 108409-108409
Closed Access | Times Cited: 34
Seyedeh Ameneh Beheshti, Karim Shamsasenjan, Majid Ahmadi, et al.
International Immunopharmacology (2021) Vol. 102, pp. 108409-108409
Closed Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
CAR T therapy beyond cancer: the evolution of a living drug
Daniel Baker, Zoltàn Arany, Joseph A. Baur, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 707-715
Closed Access | Times Cited: 221
Daniel Baker, Zoltàn Arany, Joseph A. Baur, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 707-715
Closed Access | Times Cited: 221
The emerging role of regulatory cell-based therapy in autoimmune disease
Farbod Ghobadinezhad, Nasim Ebrahimi, Fatemeh Mozaffari, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Farbod Ghobadinezhad, Nasim Ebrahimi, Fatemeh Mozaffari, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
Carlos M. Moreno, Christopher Haynie, Abigail Cheever, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1493-1493
Open Access | Times Cited: 25
Carlos M. Moreno, Christopher Haynie, Abigail Cheever, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1493-1493
Open Access | Times Cited: 25
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
T-regulatory cells for the treatment of autoimmune diseases
Marina Fisher, С. В. Сенников
Frontiers in Immunology (2025) Vol. 16
Open Access
Marina Fisher, С. В. Сенников
Frontiers in Immunology (2025) Vol. 16
Open Access
Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm
Giuseppe A. Ramirez, Chiara Cardamone, Sara Lettieri, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Giuseppe A. Ramirez, Chiara Cardamone, Sara Lettieri, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases
Liming Li, Yong He, Junpeng Zhao, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Liming Li, Yong He, Junpeng Zhao, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
PEGylated Nanocarriers for Gene Therapy
Lopamudra Mishra, Lakshmi Kumari, Yash Pal Sharma, et al.
(2025), pp. 239-273
Closed Access
Lopamudra Mishra, Lakshmi Kumari, Yash Pal Sharma, et al.
(2025), pp. 239-273
Closed Access
Biological functions and therapeutic applications of human mucosal-associated invariant T cells
Ying Fang, Yuning Chen, Shaoqiang Niu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Ying Fang, Yuning Chen, Shaoqiang Niu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief review
María Fernanda Segovia, Diana Landoni, Yohana Defranchi, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
María Fernanda Segovia, Diana Landoni, Yohana Defranchi, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Dysregulation and therapeutic prospects of regulatory T cells in type 1 diabetes
Azharuddin Sajid Syed Khaja, Naif K. Binsaleh, Husam Qanash, et al.
Acta Diabetologica (2025)
Closed Access
Azharuddin Sajid Syed Khaja, Naif K. Binsaleh, Husam Qanash, et al.
Acta Diabetologica (2025)
Closed Access
Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity
Zhongyi Jiang, Haitao Zhu, Pusen Wang, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 20
Zhongyi Jiang, Haitao Zhu, Pusen Wang, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 20
CARs: a new approach for the treatment of autoimmune diseases
Yeting Sun, Yeshuang Yuan, Bo Zhang, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 711-728
Open Access | Times Cited: 17
Yeting Sun, Yeshuang Yuan, Bo Zhang, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 711-728
Open Access | Times Cited: 17
Cellular and molecular imaging of CAR-T cell-based immunotherapy
Longwei Liu, Chi Woo Yoon, Zhou Yuan, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115135-115135
Closed Access | Times Cited: 8
Longwei Liu, Chi Woo Yoon, Zhou Yuan, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115135-115135
Closed Access | Times Cited: 8
Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions
Leonard Knoedler, J. H. Dean, Fortunay Diatta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Leonard Knoedler, J. H. Dean, Fortunay Diatta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease
Honghong Duan, Zhengrong Jiang, Lijun Chen, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110873-110873
Open Access | Times Cited: 6
Honghong Duan, Zhengrong Jiang, Lijun Chen, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110873-110873
Open Access | Times Cited: 6
Translation of cell therapies to treat autoimmune disorders
Jinal M. Mehta, Shivani C. Hiremath, Chishiba Chilimba, et al.
Advanced Drug Delivery Reviews (2023) Vol. 205, pp. 115161-115161
Closed Access | Times Cited: 5
Jinal M. Mehta, Shivani C. Hiremath, Chishiba Chilimba, et al.
Advanced Drug Delivery Reviews (2023) Vol. 205, pp. 115161-115161
Closed Access | Times Cited: 5
Development of an ostrich-derived single-chain variable fragment (scFv) against PTPRN extracellular domain
Hamed Dabiri, Majid Sadeghizadeh, Vahab Ziaei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Hamed Dabiri, Majid Sadeghizadeh, Vahab Ziaei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Non-coding RNA and Atherosclerosis
Aram Adyan, Evgeny E. Bezsonov, Eugene S. Grebenshchikov, et al.
Gene Expression (2024) Vol. 23, Iss. 1, pp. 57-68
Open Access | Times Cited: 1
Aram Adyan, Evgeny E. Bezsonov, Eugene S. Grebenshchikov, et al.
Gene Expression (2024) Vol. 23, Iss. 1, pp. 57-68
Open Access | Times Cited: 1
CAR T treatment beyond cancer: Hope for immunomodulatory therapy of non-cancerous diseases
Zhibo Yang, Yingfeng Liu, Zhao Hai
Life Sciences (2024) Vol. 344, pp. 122556-122556
Open Access | Times Cited: 1
Zhibo Yang, Yingfeng Liu, Zhao Hai
Life Sciences (2024) Vol. 344, pp. 122556-122556
Open Access | Times Cited: 1
CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases
Ananya Reddy Cingireddy, Brianna Flores, John Wuthrich, et al.
Cureus (2024)
Open Access | Times Cited: 1
Ananya Reddy Cingireddy, Brianna Flores, John Wuthrich, et al.
Cureus (2024)
Open Access | Times Cited: 1
Exercise, autoimmune diseases and T-regulatory cells
Miri Blank, Daphna Israeli, Yehuda Shoenfeld
Journal of Autoimmunity (2024) Vol. 149, pp. 103317-103317
Closed Access | Times Cited: 1
Miri Blank, Daphna Israeli, Yehuda Shoenfeld
Journal of Autoimmunity (2024) Vol. 149, pp. 103317-103317
Closed Access | Times Cited: 1
Breaking barriers: advancing cellular therapies in autoimmune disease management
Yanhong Fu, Chunjing Feng, Shan Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Yanhong Fu, Chunjing Feng, Shan Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Advances in chimeric antigen receptor T cell therapy for autoimmune and autoinflammatory diseases and their complications
Liuting Zeng, Yan Li, Xiang Wang, et al.
Journal of Autoimmunity (2024) Vol. 150, pp. 103350-103350
Closed Access | Times Cited: 1
Liuting Zeng, Yan Li, Xiang Wang, et al.
Journal of Autoimmunity (2024) Vol. 150, pp. 103350-103350
Closed Access | Times Cited: 1
Reprogramming T cells as an emerging treatment to slow human age-related decline in health
Philip V. Peplow
Frontiers in Medical Technology (2024) Vol. 6
Open Access
Philip V. Peplow
Frontiers in Medical Technology (2024) Vol. 6
Open Access